European Journal of Rheumatology
Original Article

Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behçet’s disease

1.

Department of Medical Biology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey

2.

Department of Medical Genetics, Hitit University School of Medicine, Çorum, Turkey

3.

Department of Opthalmology, Gaziosmanpaşa University School of Medicine, Tokat, Turkey

4.

Department of Biostatistics, Gaziosmanpaşa University School of Medicine, Tokat, Turkey

Eur J Rheumatol 2018; 5: 27-31
DOI: 10.5152/eurjrheum.2017.16102
Read: 2636 Downloads: 940 Published: 03 September 2019

Abstract

Objective: Behçet’s disease (BD), a chronic multisystem inflammatory disorder, is mainly characterized by relapsing periods of a wide range of clinical symptoms. Several cytokine genes may play important roles in the pathogenesis of BD. Therefore, interleukin-1 receptor antagonist (IL-1Ra) gene 86bp variable number tandem repeat (VNTR) variant was investigated in patients with BD in a Turkish population.

 

Methods: One hundred nine patients (60 females, 49 males; the mean age±standard deviation [SD] was 36.56±9.571 years) with BD and one hundred healthy individuals (54 females, 46 males; the mean age±SD was 36.64±2.294 years) were examined in the study. For genotyping, polymerase chain reaction-restriction fragment length polymorphism analysis was employed. Data were analyzed using Statistical Package for Social Sciences (SPSS) 22.0 (p<0.05).

 

Results: The genotype distribution and allele frequencies of the IL-1Ra VNTR variant did not differ significantly between the patients and the controls (p>0.05). The frequency of the a1/a1, a1/a2 genotypes and a1, a2 alleles were the most common both in patients and healthy controls (p=0.37, p=0.26, and p=0.53, respectively). Also, no statistically significant difference was found between the IL-1Ra VNTR variant genotypes and clinical characteristics (p>0.05).

 

Conclusion: The results of this study do not support an association between the IL-1Ra VNTR variant and the risk of BD in a Turkish population. However, further studies of this variant with larger sample sizes and different ethnicities are required for confirmation. 

 

Cite this article as: Dursun G, Nursal AF, Deniz Demir H, Karakuş N, Demir O, Yiğit S. Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behçet’s disease. Eur J Rheumatol 2018; 5: 27-31.

Files
EISSN 2148-4279